Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Return on Invested Capital (2019 - 2026)

10x Genomics' Return on Invested Capital history spans 7 years, with the latest figure at 0.0% for Q4 2025.

  • On a quarterly basis, Return on Invested Capital changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Invested Capital hit 0.0% in Q4 2025 for 10x Genomics, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Invested Capital for TXG hit a ceiling of 0.0% in Q4 2021 and a floor of 0.01% in Q1 2021.
  • Historically, Return on Invested Capital has averaged 0.0% across 5 years, with a median of 0.0% in 2025.
  • The widest YoY moves for Return on Invested Capital: up 1bps in 2021, down -1bps in 2021.
  • Tracing TXG's Return on Invested Capital over 5 years: stood at 0.0% in 2021, then plummeted by -211bps to 0.0% in 2022, then crashed by -68bps to 0.0% in 2023, then rose by 24bps to 0.0% in 2024, then skyrocketed by 70bps to 0.0% in 2025.
  • Business Quant data shows Return on Invested Capital for TXG at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.